ReviewDrugs2021
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
Eduardo Mysler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this paperpooled ittrialcites it
ReviewDrugs2021
Eduardo Mysler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.